CompanyGraph
AddLife AB
ALIF.B · Nasdaq Stockholm · Sweden
Price data from its ALIFBs listing on CBOE
add.lifeFinancials as of FY2025
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $1.99B, above the global median of $1.15B
- FinancialsAltman Z-Score 2.65: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.92%
Annual Rate
SEK 1.50Paid annual
Payout Ratio
30.7%Sustainable
Last Ex-Dividend
May 7, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
18.90BSEK1.99B · vs all stocks (USD)
Trailing P/E
32.82xvs Medical Instruments & Supplies peers
Revenue (TTM)
10.53BSEK1.11B · vs all stocks (USD)
Profit Margin
5.68%vs Medical Instruments & Supplies peers
Beta
1.55xvs all stocks
52-Week Change
-6.03%vs all stocks
Market Capitalization
18.90BSEK1.99B · vs all stocks (USD)
Enterprise Value
23.86BSEK2.51B · vs all stocks (USD)
Trailing P/E
32.82xvs Medical Instruments & Supplies peers
Forward P/E
50.47xvs Medical Instruments & Supplies peers
PEG Ratio
4.02xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
1.86xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
3.44xvs Medical Instruments & Supplies peers
Enterprise to Revenue
2.27xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
16.54xvs Medical Instruments & Supplies peers
Gross Margin
39.47%vs Medical Instruments & Supplies peers
Profit Margin
5.68%vs Medical Instruments & Supplies peers
Operating Margin
8.67%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
4.17%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
10.94%vs Medical Instruments & Supplies peers
Revenue (TTM)
10.53BSEK1.11B · vs all stocks (USD)
Revenue per Share (TTM)
86.39SEKUpdated Aug 21, 2026Quarterly Revenue Growth
5.50%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
4.05BSEK426.29M · vs all stocks (USD)
EBITDA (TTM)
1.06BSEK111.47M · vs all stocks (USD)
Net Income (TTM)
598.00MSEK63.01M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
30.00%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
1.30BSEK137.18M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
786.50MSEK82.87M · vs all stocks (USD)
Trailing Annual Dividend Rate
1.50SEKUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.92%vs all stocks
Payout Ratio
30.67%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
4.00MSEKFY2025 · Dec 31, 2025Revenue
10.44BSEKFY2025 · Dec 31, 2025Cost of Goods Sold
6.46BSEKFY2025 · Dec 31, 2025Gross Profit
3.98BSEKFY2025 · Dec 31, 2025Operating Income
993.00MSEK104.62M · vs all stocks (USD)
Pre-tax Income
772.00MSEKFY2025 · Dec 31, 2025Income Tax Expense
210.00MSEKFY2025 · Dec 31, 2025Net Income
562.00MSEKFY2025 · Dec 31, 2025EBIT
993.00MSEKFY2025 · Dec 31, 2025EBITDA (Income Statement)
993.00MSEKFY2025 · Dec 31, 2025Research & Development
57.00MSEKFY2025 · Dec 31, 2025Selling, General & Administrative
3.14BSEKFY2025 · Dec 31, 2025Other Operating Expenses
-213.00MSEKFY2025 · Dec 31, 2025EPS (Basic)
4.59SEKFY2025 · Dec 31, 2025EPS (Diluted)
4.59SEKFY2025 · Dec 31, 2025Basic Shares Outstanding
121.86MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
121.86MSharesFY2025 · Dec 31, 2025Minority Interests (P&L)
-2.00MSEKFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00SEKFY2025 · Dec 31, 2025Operating Cash Flow
1.02BSEKFY2025 · Dec 31, 2025Free Cash Flow
808.00MSEKFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
813.00MSEKFY2025 · Dec 31, 2025Starting Profit (CF Statement)
772.00MSEKFY2025 · Dec 31, 2025Other Non-cash Items
219.00MSEKFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-13.00MSEKFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
42.00MSEKFY2025 · Dec 31, 2025Capital Expenditures
-212.00MSEKFY2025 · Dec 31, 2025Net Intangibles (CF)
-42.00MSEKFY2025 · Dec 31, 2025Net Acquisitions
-247.00MSEKFY2025 · Dec 31, 2025Purchase of Investments
-1.00MSEKFY2025 · Dec 31, 2025Sale of Investments
5.00MSEKFY2025 · Dec 31, 2025Other Investing Activity
-254.00MSEKFY2025 · Dec 31, 2025Net Investing Cash Flow
-709.00MSEKFY2025 · Dec 31, 2025Long-term Debt Issuance
20.00MSEKFY2025 · Dec 31, 2025Long-term Debt Payments
-50.00MSEKFY2025 · Dec 31, 2025Common Dividends Paid
-91.00MSEKFY2025 · Dec 31, 2025Net Financing Cash Flow
-121.00MSEKFY2025 · Dec 31, 2025Shares Outstanding
121.86MSharesUpdated Aug 21, 2026Float Shares
113.27MSharesUpdated Aug 21, 2026% Held by Insiders
5.18%vs all stocks
% Held by Institutions
71.44%vs all stocks
Total Cash (MRQ)
394.00MSEK41.51M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.23SEKUpdated Aug 21, 2026Total Debt (MRQ)
5.02BSEK529.01M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.8813xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.01xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
46.71SEKUpdated Aug 21, 2026Total Assets
12.71BSEK1.34B · vs all stocks (USD)
Total Current Assets
4.15BSEKFY2025 · Dec 31, 2025Total Liabilities
7.26BSEKFY2025 · Dec 31, 2025Total Non-current Assets
8.56BSEKFY2025 · Dec 31, 2025Total Non-current Liabilities
3.27BSEKFY2025 · Dec 31, 2025Total Current Liabilities
3.99BSEKFY2025 · Dec 31, 2025Cash & Cash Equivalents
813.00MSEKFY2025 · Dec 31, 2025Accounts Receivable
1.68BSEKFY2025 · Dec 31, 2025Inventory
1.65BSEKFY2025 · Dec 31, 2025Short-term Debt
1.94BSEKFY2025 · Dec 31, 2025Other Current Liabilities
2.00BSEKFY2025 · Dec 31, 2025Long-term Debt
2.83BSEKFY2025 · Dec 31, 2025Other Non-current Liabilities
31.00MSEKFY2025 · Dec 31, 2025Total Shareholders' Equity
5.45BSEK573.90M · vs all stocks (USD)
52-Week Low
130.20SEKUpdated Aug 21, 202652-Week High
208.40SEKUpdated Aug 21, 202652-Week Change
-6.03%vs all stocks
Beta
1.55xvs all stocks
50-Day MA
161.29SEKUpdated Aug 21, 2026200-Day MA
155.93SEKUpdated Aug 21, 2026Avg 10-Day Volume
123.52KSharesUpdated Aug 21, 2026Avg 30-Day Volume
104.50KSharesUpdated Aug 21, 2026Diluted EPS (TTM)
4.89SEKUpdated Aug 21, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.65: safe zoneNotable
Altman Z-Score: 2.65
High earnings qualityNotable
Earnings Quality Score: 1.05
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $1.99B, above the global median of $1.15BNotable
Market cap (USD): 1,991,421,695.443Global Median: 1,146,734,693.424
Revenue is $1.11B, above the global median of $520.53MNotable
Revenue (USD): 1,109,230,080Global Median: 520,528,949.311
Levered free cash flow is $82.87M, above the global median of $16.24MNotable
Levered free cash flow (USD): 82,865,636.628Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Swcc Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Gongjin Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Xizi Clean Energy Equipment Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Anhui Jiangnan Chemical Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang E-P Equipment Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Aarti Industries Limited
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Pulse Biosciences Inc.
Tier 1ProductionThroughput-Bound ConversionRule
Sumec Corporation Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowInterface
India Cements Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Greatek Electronics Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Boji Medical & Technology Co., Ltd.
3 interpretationsRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked Return on Capital Elevated
Anker Innovations Technology Co., Ltd.
3 interpretationsRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked Return on Capital Elevated
Maruchiyo Yamaokaya Corp.
3 interpretationsRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked Return on Capital Elevated